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ABSTRACT 
Objective: To compare the sensitivity and specificity of three 
different assays for diagnosis of invasive candidiasis. 
Methods: A passive hemagglutination assay (PHA), counter- 
immunoelectrophoresis assay (CIE), and Cand-tee were used 
to test sera from 125 patients with hematologic malignancies 
and 65 other hospitalized patients. The former group included 
15 patients with invasive candidiasis, 38 patients with Candida 
colonization, and 72 patients without candidiasis. 
Results: Sensitivity/specificity of PHA, CIE, and Cand-tee were 
87%/85%, 67%/98%, and 33%/97%, respectively. The mea- 
surement of antibody in paired sera, by PHA, was sensitive 
and specific; however, increased antibody titers usually occurred 
late in the disease. 
Conclusions: The combination of PHA and CIE, with a sensi- 
tivity of 67% and specificity of 98%, appeared to be the best 
assays for detection of invasive candidiasis in this cohort. The 
Cand-tee assay for Candida antigen had poor sensitivity for 
diagnosis of infection. 
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Deep-seated mycosis remains a major infectious compli- 
cation among patients with leukemia, malignant lym- 
phoma, and other neoplasms, and among transplant 
recipients. Invasive candidiasis is the most common seri- 
ous opportunistic fungal infection among these patients. 
Although there have been improvements in antifungal 
therapy, there is a need for more sensitive and reliable 
methods to diagnose invasive candidiasis. 
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The serologic diagnosis of candidiasis has been 
explored by many investigators, with conflicting 
results. l-6 Detection of antibody has generally been unsuc- 
cessful, because these immunocompromised patients are 
incapable of mounting a brisk humoral response to infec- 
tion. Detection of antigen may also be difficult since Cun- 
dida appears to disseminate only scant quantities of 
antigen into body fluids and many of these antigens, 
because they form complexes with antibodies or other 
serum proteins, do not reach detectable concentrations 
in serum. 
The sensitivity and specificity of three different sero- 
logic assays were compared for diagnosis of invasive can- 
didiasis: a passive hemagglutination assay (PHA), 
counterimmunoelectrophoresis assay (CIIE), and 
Cand-tee (Ramco Laboratories, Houston, TX, USA). 
These assays were used to test serum from patients with 
and without candidiasis. 
MATERIAL AND METHODS 
Patients and Controls 
The cohort included 15 patients with hematologic dis- 
orders who had invasive candidiasis and 110 patients 
who did not. All had been admitted to the First Depart- 
ment of Internal Medicine, Kyushu University 
The diagnosis of invasive candidiasis was based on 
the following criteria: histopathologic proof or isola- 
tion of Cundida spp from autopsy specimens (cases 7, 
12, and 13) or from sterile site biopsy (cases 8-l 1 and 
14) and isolation of more than two positive blood cul- 
tures of Candida spp from specimens taken with at 
least a 24-hour interval from different sites (cases 1-6 
and 15) (Table 1). 
Underlying diseases included three cases of myelodys- 
plastic syndrome (MDS), three cases of malignant lym- 
phoma (ML), two cases of acute myelocytic leukemia 
&ML), two cases of adult T-cell leukemia (ATL), and one 
case each of hairy cell leukemia, acute promyelocytic 
leukemia (APL), acute lymphocytic leukemia (ALL), acute 
monocytic leukemia (AMoL), and acute myelomonocytic 
leukemia (AMMoL). Mean age of the patients was 38 years 
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No. Sex 
Table 1. Invasive Candidiasis with Hematologic Disorders 
Age W Underlying Disease Candidiasis Organism 
1 M 19 MDS Candidemia C. parapsilosis 
2 M 71 Hairy cell leukemia Candidemia C. tropicalis 
3 M 25 MDS Candidemia C. glabrata 
4 M 32 APL Candidemia C. a/b/cans 
5 M 17 ALL Pulmonary C. albicans 
6 M 16 ML Pulmonary C. albicans 
7 M 66 ATL Pulmonary Candida spp 
a M 25 ML GI-tract C. albicans 
9 M 31 AML GI-tract C. albicans 
10 F 22 ML GI-tract C. albicans 
11 M 45 ATL GI-tract C. albicans 
12 F 54 AMoL Liver abscess Candida spp 
13 F 41 AML Renal abscess Candida spp 
14 F 25 AMMoL Arthritis C. albicans 
15 F 78 MDS Urinary C. albicans 
MDS = myelodysplastic syndrome; ML = malignant lymphoma; AML = acute myelocytic leukemia; ATL = adult T-cell leukemia; APL = acute promyelocytic leukemia; 
ALL = acute lymphocytic leukemia; AMoL = acute monocgic leukemia: AMMoL = acute myelomonocytic leukemia; GI-tract = gastroinWhx4 tract. 
(range, 16-78 yr). There were ten male and five female 
patients (see Table 1). Sixty serum samples were col- 
lected from the patients with invasive candidiasis. 
ferent antibody titers were obtained from the same 
patient, the highest titer was used for the analysis. 
Controls consisted of four groups: group 1, 80 serum 
samples obtained from 38 afebrile patients with hema- 
tologic disorders, who had Candida isolated from spu- 
tum, urine, or stool; group 2, 170 serum samples 
collected from 72 patients with hematologic disorders 
who had negative surveillance cultures for Candida; 
group 3, 42 serum samples from 42 healthy hospital staff 
members; and group 4, 23 serum samples from 23 febrile 
patients with shigellosis. The latter group was included 
to explore the effects of intestinal infection and mucosal 
injury on the interaction between Candida and the host. 
Counterimmunoelectropboresis Assay 
Antigen Detection 
Cand-tee was used to detect the Candida antigen. Tests 
were done according to the manufacturer’s instructions. 
Antibody Detection 
Passive Hemagglutination Assay 
Two types of Candida antigens were used in the CIE 
assay. One was Candida antigen for the allergen test 
(Iorii Co., Tokyo, Japan), which consisted of non-mannan 
antigens, and the other was mannan prepared from a 
clinical isolate of Candida albicans, by the method of 
Reiss et al.’ The CIE assay was performed in a Gelman 
electrophoretic chamber (Gelman, Ann Arbor, MI, USA) 
with 8 X 10 cm glass slides: 0.8% agarose (Behringer, 
Germany) and 0.4% sodium citrate (Kant0 Kagaku, Japan) 
in a 0.07 M barbital buffer, pH 8.6 (Cosmo, Tokyo, Japan) 
was poured onto the glass and two wells measuring 3 mm 
in diameter were cut 3 mm apart. Antisera were loaded 
on the anodal side. Electrophoresis of samples was con- 
ducted for 60 minutes at room temperature, with a cur- 
rent of 20 mA, in 0.07 M of barbital buffer, pH 8.6. 
Precipitation lines were confirmed after cooling 16 hours 
at 4°C. 
The Candida albicans hemagglutination assay antigen The sensitivity, specificity, and predictive values were 
test (Hoffmann-La Roche Diagnostica, Basel, Switzerland) all calculated as described by Vecchio,* Feinsteiq9 and 
was used to detect Candida antibody. When several dif- McNeill et al.1° 
Table 2. Serologic Results among Patients with Hematologic Disorders and Invasive 
Candidiasis, Asymptomatic Patients, and Controls 
Group 
Antibody Test Antigen Test 
PHA 
C/E 
Cand-Tee 
(inters 2 7:32CJ) n (%) Mannan n (%j Non-Mannan n (%) (Titers 2 1.4) n (%) 
Patients (n = 125) 
Candidiasis (n = 15) i 3 (87) 
With Candida colonization (n = 38) 11 (29) 
Without Candida colonization (n = 72) 16 (22) 
Controls (n = 65) 
Hospital staff (n = 42) 2 (4.7) 
Shigellosis (n = 23) 1 (4.3) 
PHA = passive hemagglutination; CIE = counterimmunoelectrophoresis. 
1 (7) IO (67) 5 (33) 
0 (0) 2 (5) 0 (0) 
0 (0) 2 (3) 5 (7) 
0 0 0 (0) 0 0 
0 (0) 0 (0) 0 (0) 
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RESULTS 
Detection of Candida Antibodies 
By PHA, 13 (86.7%) of the 15 patients with invasive can- 
didiasis had serum antibody titers of 1:320 or more, com- 
pared to 11 (28.9%) in group 1; I6 (22.2%) in group 2; 
3 (4.7%) in group 3; and 1 (4.3%) in group 4 (Table 2). 
The sensitivity was 87%, and the specificity, positive pre- 
dictive value (PVP), and negative predictive value (PVN) 
were 85%, 30%, and 99%, respectively (Table 3). 
By CIE, when the non-mannan antigen was used, the 
sera of 10 (66.7%) patients with invasive candidiasis 
yielded positive results, whereas 2 (5.0%) 2 (3.0%) and 
0 patient samples were positive in groups 1, 2, and 3, 
respectively. The sensitivity was 67%, and the specificity, 
PVP and PVN were 98%, 71%, and 97%, respectively. 
When mannan antigen was used, only one (6.7%) 
patient with invasive candidiasis was positive (see Tables 
2 and 3). 
Detection of Candida Antigenemia 
A Cand-tee titer of 1:4 or greater was observed in 5 
(33.3%) of the 15 patients with invasive candidiasis. On 
the other hand, 5 (6.9%) of the patients with hemato- 
logic disorders who lacked evidence of Candida infec- 
tion or colonization (group 2) showed positive results, 
and none of the patients in groups 1, 3, and 4 were pos- 
itive (see Table 2). The Cand-tee test showed a low sen- 
sitivity of 33.3%, but a specificity of 97%, PVP of 50%, and 
PVN of 95% (see Table 3). 
Other Observations 
Figure 1 shows Candida antibody titers by PHA or CIE 
with non-mannan antigen. When a positive result was 
scored only if both assays were positive, there were three 
false positives and five false negative cases. The sensitiv- 
ity was 67%; the specificity, PVP, and PVN were 98%, 
77%, and 97%, respectively (see Table 3). 
The sequential change of PHA titers in pairs of serum 
was also analyzed. This consisted mostly of serum spec- 
imens taken at admission and during or after a febrile 
episode (Figure 2). The antibody titers of 10 of 15 
patients with invasive candidiasis were elevated twofold 
Table 3. Comparison of Assays for Diagnosis 
of Invasive Candidiasis 
C/E 
PHA Non-Mannan Mannan PHA+CIE Can&Tee 
Sensitivity (%) 87 67 7 67 33 
Specificity (%) 85 98 100 98 97 
PVP (%) 30 71 100 77 50 
PVN (%) 99 97 93 97 95 
PHA = passive hemagglutination; CIE = counterimmunoelectrophoresis; 
PVP = positive predictive value; PVN = negative predictive value. 
or more, whereas only three cases among 57 patients 
without Candida infection showed antibody titer 
elevation. 
The results of the three antibody tests and the one 
antigen detection test in the 15 patients with invasive 
candidiasis are summarized in Table 4. In the detection 
of Candida antigen by Cand-tee, five (33%) of the 
patients were positive. Four patients with gastrointesti- 
nal candidiasis and three patients with pulmonary can- 
didiasis were negative. In the antibody detection of 
candidiasis by CIE with non-mannan antigen, ten (67%) 
patients had positive results, and there were no correla- 
tions between the types of infection and positivity. When 
using mannan antigen, only one patient with candidiasis 
yielded a positive result, 
DISCUSSION 
The diagnosis of serious Candida infections remains 
problematic. Colonization of nonsterile sites may provide 
an opportunity for invasion; however, the detection of 
colonization does not identify those patients who will 
require systemic therapy. Antemortem blood cultures are 
negative in many patients with autopsy-proven dissemi- 
nated Candida infections. 
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Figure 1. PHA titer and CIE in the patient groups (n = 125) and con- 
trol group (n = 65). 
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of these are commercially marketed tests that are com- 
monly used to decide whether to treat patients for can- 
didiasis. False negative results may have significant 
adverse consequences if they prompt physicians to with- 
hold treatment of this life-threatening infection. False pos- 
itive results may also be harmful as patients may 
needlessly receive toxic antifungal therapies. 
The PHA assay was sensitive: when titers in excess 
of 1:32O were defined as positive, 87% of patients with 
invasive candidiasis developed positive titers. Unfortu- 
nately, 4.5% of samples from healthy hospital workers 
and 29% and 22% of patients in control groups 1 and 2 
also yielded positive results. Kostiala and Kostiala reported 
a false positive ratio of 3% using this method.” 
Bisbe et al showed that positive PHA tests with a titer 
in excess of 1:2560 strongly suggested a Candida infec- 
ti0n.l’ By this criteria, 6 (40%) of 15 patients with invasive 
candidiasis were positive, and two (1%) control patients 
without invasive candidiasis yielded false positive results. 
It has been suggested that a serologic diagnosis is 
difficult in those situations because the immunocom- 
promised hosts cannot produce a sufficient amount of 
Candida antibody. 13s1* However, 9 of 15 patients with 
invasive candidiasis had a threefold or greater increase in 
antibody titers, whereas 3 of 57 asymptomatic patients 
showed antibody titer elevation of three times or more, 
and only one case had a titer of 1: 320 or higher. Thus the 
examination of PHA with paired serum samples has some 
diagnostic value. 
With the CIE method, non-mannan antigen or mannan 
antigen was used. The sensitivity and specificity with non- 
mannan antigen were 67% and 98%, whereas with man- 
nan antigen they were 7% and lOO%, respectively Bisbe 
et al and Dee et al reported similar results with CIE.12J5 
Antigen, rather than antibody detection has been 
advocated for early diagnosis of candidiasis. The Cand-tee 
test for Candida antigen was insensitive in this study. Its 
Figure 2. The relation between PHA titer and candidiasis using paired 
serum specimens (n = 67). 
In this study, tests for Candida antigen and anti- 
bodies were evaluated for diagnosis of invasive candidi- 
asis among patients with hematologic disorders. Some 
Table 4. Clinical Features and Serologic Results 
NO. invasive Candidiasis 
Antigen Test 
Cand-Tee Titer 
Antibody Test 
C/E PHA Rheumatoid 
Mannan Non-Mannan Titer Peak Arthritis Factor 
1 Candidemia I:8 
2 Candidemia - 
3 Candidemia I:4 
4 Candidemia 1:4 
5 Pulmonary I:2 
6 Pulmonary 1:2 
7 Pulmonary I:2 
8 GI-tract - 
9 GI-tract - 
10 GI-tract - 
11 GI-tract - 
12 Liver abscess 1:2 
13 Renal abscess 1:4 
14 Arthritis - 
15 Urinary I:4 
CIE = counterimmunoelectrophoresis; PHA = passive hemagglutination. 
- = negative result; + = positive result. 
- + 5120x - 
- - 320x - 
- + 1280x - 
- - 1280x - 
- f 1280x - 
- + 2560x - 
- 10x - 
- + 5102x - 
- + 640x - 
- + 5102x - 
- - 20x - 
- - 320x - 
- + 320x - 
+ + 5120x - 
- + 2560x + 
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sensitivity was 33%, and its specificity was 97% (PVp 
50%; PVN, 95%). This suggests that reliance on this assay 
might result in two cases missed for every case detected. 
This low sensitivity makes the test an unacceptable guide 
for treatment decisions. 
Ness et al reported that the Cand-tee test had a sen- 
sitivity of 54.5%, a specificity of 29%, PVP of 17%, and 
PVN of 70.5%.16 Bougnoux et al also reported a sensitiv- 
ity of 29% and a specificity of 97%.” Jones came to sim- 
ilar conclusions.18 If a 1:s or greater titer were considered 
to be positive, Fung et al reported a sensitivity of 71% and 
a specificity of 984 o i9 but, using these criteria, data from 
the present study show a sensitivity of 7% and a speci- 
ficity of 99%. 
By combining the PIIA and CIE with non-mannan 
antigen methods, higher diagnostic significance was 
obtained than with either method alone. The sensitivity 
of the combined tests was 67%, and the specificity was 
98%. The antigens used in these tests were polysaccha- 
rides, including mannan in the PHA test and non-man- 
nan proteins in the CIE test. 
The combination of two tests for Candida antibody 
was a sensitive and specific method for diagnosis of inva- 
sive candidiasis. These tests do not, however, provide an 
early diagnosis that reliably indicates when treatment 
should be initiated. 
With current tests, antigen detection misses most 
infected patients and antibody detection is too late. Nei- 
ther test provides a reliable indicator of who should be 
treated and when treatment should start or stop. 
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